Company profile
Resolve Nanotherapeutics Corp.
Developing next-generation therapeutics for acute bacterial infections
- Industry
- Nanotechnology Research
- Employees
- 3
- Headquarters
- Vancouver, BC
- Founded
- 2024
- LinkedIn followers
- 133
- Office locations
- 1
Resolve Nanotherapeutics Corp. company summary
Resolve Nanotherapeutics Corp. is a company in the Nanotechnology Research industry, headquartered in Vancouver, BC, founded in 2024. On LinkedIn the company has around 3 employees and 133 followers.
What technology does Resolve Nanotherapeutics Corp. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Resolve Nanotherapeutics Corp.
Resolve Nanotherapeutics (RNTx) is developing completely novel drugs for severe infections such as pneumonia, abdominal infections and others. These types of infections kill millions of people every year and our current frontline treatments – antibiotics – are rapidly losing their effectiveness due to the rise in antibiotic resistance. RNTx is taking a host-directed approach to address this problem and using cutting-edge lipid nanoparticle (LNP) RNA technology to activate the body’s natural toxin clearance systems, ultimately overcoming the devastating clinical complications and vital organ dysfunction that accompany these types of severe infections. RNTx is the product of a collaboration between the UBC labs of Dr. Pieter Cullis (LNP expert) and Dr. James Russell (critical care physician and researcher) developing de-risked technology packages in pre-clinical models of severe infection. Studies to date have demonstrated remarkable efficacy in an in vivo model of pneumonia caused by antibiotic resistant bacteria. The key strengths of the technology are: (1) that the approach is organism and antibiotic resistance agnostic, (2) it does not create a selective pressure for new resistance development, ensuring a sustained market once approved and, (3) it uses clinically validated components (LNPs and RNA) that can readily be scaled for manufacturing and widespread distribution.
Where is Resolve Nanotherapeutics Corp. located?
Resolve Nanotherapeutics Corp. lists 1 location.
Compare companies similar to Resolve Nanotherapeutics Corp.
More companies in Nanotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Resolve Nanotherapeutics Corp. resolventx.com | Nanotechnology Research | 3 | 2024 | Vancouver, BC |
 ZEISS Microscopy zeiss.com | Nanotechnology Research | 2,027 | 1846 | Jena, Thüringen |
| Nanotechnology Research | 502 | 2008 | Braga, Braga | |
 Quandela quandela.com | Nanotechnology Research | 163 | 2017 | Massy, Île-de-France |
 QuTech qutech.nl | Nanotechnology Research | 218 | 2014 | Delft, Zuid-Holland |
 Vesiculab vesiculab.com | Nanotechnology Research | 5 | - | Nottingham, Nottinghamshire |
 Nano One Materials Corp. TSX: NANO nanoone.ca | Nanotechnology Research | 81 | 2011 | Burnaby, BC |
 NoPo Nanotechnologies nopo.in | Nanotechnology Research | 54 | 2011 | Bangalore, Karnataka |
 Meta Materials Inc. (META®) metamaterial.com | Nanotechnology Research | 37 | 2011 | Halifax, Nova Scotia |
 NX Filtration nxfiltration.com | Nanotechnology Research | 140 | 2016 | Hengelo, Overijssel |
 LIGENTEC ligentec.com | Nanotechnology Research | 82 | 2016 | Ecublens, Vaud |
Frequently asked questions about Resolve Nanotherapeutics Corp.
What does Resolve Nanotherapeutics Corp. do?
Resolve Nanotherapeutics (RNTx) is developing completely novel drugs for severe infections such as pneumonia, abdominal infections and others. These types of infections kill millions of people every year and our current frontline treatments – antibiotics – are rapidly losing their effectiveness due to the rise in antibiotic resistance. RNTx is taking a host-directed approach to address this problem and using cutting-edge lipid nanoparticle (LNP) RNA technology to activate the body’s natural toxin clearance systems, ultimately overcoming the devastating clinical complications and vital organ dysfunction that accompany these types of severe infections. RNTx is the product of a collaboration between the UBC labs of Dr. Pieter Cullis (LNP expert) and Dr. James Russell (critical care physician and researcher) developing de-risked technology packages in pre-clinical models of severe infection. Studies to date have demonstrated remarkable efficacy in an in vivo model of pneumonia caused by antibiotic resistant bacteria. The key strengths of the technology are: (1) that the approach is organism and antibiotic resistance agnostic, (2) it does not create a selective pressure for new resistance development, ensuring a sustained market once approved and, (3) it uses clinically validated components (LNPs and RNA) that can readily be scaled for manufacturing and widespread distribution.
How many employees does Resolve Nanotherapeutics Corp. have?
Resolve Nanotherapeutics Corp. has around 3 employees on LinkedIn.
Where is Resolve Nanotherapeutics Corp. headquartered?
Resolve Nanotherapeutics Corp. is headquartered in Vancouver, BC.
When was Resolve Nanotherapeutics Corp. founded?
Resolve Nanotherapeutics Corp. was founded in 2024.
Build a lead list from companies like Resolve Nanotherapeutics Corp.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.